CN106316826B - The preparation method of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents - Google Patents

The preparation method of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents Download PDF

Info

Publication number
CN106316826B
CN106316826B CN201610559928.2A CN201610559928A CN106316826B CN 106316826 B CN106316826 B CN 106316826B CN 201610559928 A CN201610559928 A CN 201610559928A CN 106316826 B CN106316826 B CN 106316826B
Authority
CN
China
Prior art keywords
rare earth
oba
preparation
dicarboxydiphenyl ether
earth complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201610559928.2A
Other languages
Chinese (zh)
Other versions
CN106316826A (en
Inventor
刘翔宇
李菲菲
岑培培
宋伟明
曹良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ningxia University
Original Assignee
Ningxia University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ningxia University filed Critical Ningxia University
Priority to CN201610559928.2A priority Critical patent/CN106316826B/en
Publication of CN106316826A publication Critical patent/CN106316826A/en
Application granted granted Critical
Publication of CN106316826B publication Critical patent/CN106316826B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41Preparation of salts of carboxylic acids
    • C07C51/418Preparation of metal complexes containing carboxylic acid moieties

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A kind of preparation method of 4,4 ' dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents, includes the following steps:(1) by H2OBA (4,4 ' dicarboxydiphenyl ether) is dissolved in the in the mixed solvent of DMF and water, and rare earth nitrades Re (NO are added3)3, wherein one kind in tetra- kinds of Re La, Ce, Sm, Er rare earth elements, H2OBA and Re (NO3)3Molar ratio be 1: (1.3~2.2);(2) 10~30min is stirred at room temperature after it becomes five colors clarification from cotton-shaped suspension in the solution of step (1), be fitted into the reaction kettle of polytetrafluoroethyllining lining, in 120 ± 1 DEG C of 70~72h of constant temperature;(3) 10~12h is kept the temperature when the reactant after constant temperature being down to 100 ± 2 DEG C, room temperature is then down to the rate of 6 DEG C/h, obtains [Re2(OBA)3(H2O)5]·H2O.Synthetic method of the present invention is simple, and generated time is short, and yield is high, and the generated time of the rare earth complex compoud currently used for bacteriostatic agent is shortened half.

Description

The preparation method of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents
Technical field:
The present invention relates to the synthesis technical fields of carboxylic acids rare earth complex compoud, specifically, being related to one kind 4,4 '-two The preparation method of carboxyl diphenyl ether rare earth complex compoud bacteriostatic agent.
Background technology:
In recent years, with the research to rare earth compound, unique property make its high-technology field demand not Disconnected increase.Luminous, fluorescence and catalytic field are concentrated mainly on to the research of rare earth material at present, consumption market is mainly concentrated In U.S., day, Europe, it is related to including the production of the technologies such as cleaning catalyst for tail gases of automobiles, petroleum refining catalyst, permanent-magnet material, fluorescent powder Industry.Such as:Changchun Inst. of Applied Chemistry, Chinese Academy of Sciences application No. is 201410122975.1 patents to disclose a kind of use Make the preparation method of the lactic acid rare earth compounding of catalyst;Shanghai Silicate Inst., Chinese Academy of Sciences application No. is 200910050880.2 patent disclose a kind of preparation method of the rare earth compounding as luminescent material.
The advantages that rare earth compounding bacteriostatic agent has sterilizing ability strong, and antimicrobial spectrum is wide, and solution acidic is close to physiological pH, because This, more and more scholar are dedicated to the research of rare earth drugs both at home and abroad, and achieve gratifying achievement.Comprehensive literature report, Rare earth compounding with bacteriostasis, ligand majority are containing carboxyl, hydroxyl or sulfonic aromatic compound.Rare earth Have efficient, stable the advantages of aromatic carboxylic acids class complex integrates inorganic rare earth metal ion and organic carboxylic acid compounds Bacteriostatic activity, have important application in the fields such as chemistry, biology, pharmacy.
Currently, the reaction time needed for the synthetic method of such complex is long.Such as:Strong equal (CrystEngComm, 2013,15,315) under conditions of ethylidene-urea hemihydrate is added, rare earth compounding [Tm is obtained within 5 days in 140 DEG C of reactions2 (oba)3(H2O)5]·H2O, yield 79%;Luo Yun etc. (CrystEngComm, 2013,15,706) utilizes solvent evaporation method, Serial rare-earth complex [Ln is obtained after reaction a few weeks longer2(oba)3(H2O)5]·H2O, yield 81%.
Based on this, under conditions of ensureing yield, improving the aggregate velocity of hexichol class rare earth complex compoud becomes at present One research direction.
Invention content:
In view of the foregoing, it is necessary to it is dilute to invent 4, the 4 '-dicarboxydiphenyl ethers that a kind of yield is high and generated time is short The preparation method of native complex bacteriostatic agent.
A kind of preparation method of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents, includes the following steps:
(1) by H2OBA (4,4 '-dicarboxydiphenyl ether) is dissolved in the in the mixed solvent of DMF and water, and rare earth nitrades are added Re(NO3)3, wherein one kind in tetra- kinds of Re La, Ce, Sm, Er rare earth elements, H2OBA and Re (NO3)3Molar ratio be 1: (1.3~2.2);
(2) 10~30min is stirred at room temperature when it is become colorless clarification by cotton-shaped suspension in the solution of step (1) Afterwards, it is fitted into the reaction kettle of polytetrafluoroethyllining lining, in 120 ± 1 DEG C of 70~72h of constant temperature;
(3) 10~12h is kept the temperature when the reactant after constant temperature being down to 100 ± 2 DEG C, room is then down to the rate of 6 DEG C/h Temperature obtains target product [Re2(OBA)3(H2O)5]·H2O。
Preferably, the molar ratio of in the mixed solvent water and DMF are 1: (2~3.5).
Preferably, H2OBA and Re (NO3)3Molar ratio be 1: 1.8.
Preferably, mixing time 15min.
Preferably, step (2) thermostat temperature is 120 DEG C.
Preferably, the molar ratio of water and DMF are 1: 3.
Preferably, the solution being fitted into step (2) in reaction kettle is 15mL.
The present invention has the beneficial effect that:
Synthetic method is simple, and generated time is short, and yield is high, by the synthesis currently used for the rare earth complex compoud of bacteriostatic agent Time shortens half.
Description of the drawings:
Attached drawing 1 is the crystal structure figure of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents.
Attached drawing 2 is the powder x-ray diffraction figure of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents.
Attached drawing 3 is suppression curve figure of the various concentration complex to micrococcus luteus growth rate constant.
Specific implementation mode:
4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents, molecular formula Re2C42O21H36, (Re=La, Ce, Sm, Er), chemical formula [Re2(OBA)3(H2O)5]·H2O, crystal structure figure are as shown in Figure 1.
A kind of yield is high and the preparation of 4,4 '-short dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents of generated time Method:
Embodiment 1
(1) by 12.9mg (0.05mmol) H2OBA (4,4 '-dicarboxydiphenyl ether)It is molten In the in the mixed solvent of 12mL DMF and water, 30.24mg (0.09mmol) Sm (NO are added3)3
(2) 10~30min is stirred at room temperature when it is become colorless clarification by cotton-shaped suspension in the solution of step (1) Afterwards, it is fitted into the reaction kettle of 15mL polytetrafluoroethyllining linings, in 120 DEG C of constant temperature 72h;
(3) 11h is kept the temperature when the reactant after constant temperature being down to 100 DEG C, and room temperature is then down to the rate of 6 DEG C/h, is obtained Target product, yield 92%, (in addition curve (1), (2), (4) correspond to the curve (3) that powder diagram is shown in attached drawing 2 respectively The complex of three kinds of rare earth elements), it is [Sm that can obtain the compound by figure2(OBA)3(H2O)5]·H2O。
Embodiment 2
It is similar to Example 1, unlike:Take H2OBA 12.9mg (0.05mmol), Sm (NO3)321.84mg (0.065mmol), H2OBA and Sm (NO3)3Molar ratio be 1: 1.3, solvent-thermal method obtains target compound, yield 61%.
Embodiment 3
It is similar to Example 1, unlike:Take H2OBA 12.9mg (0.05mmol), Sm (NO3) 336.96mg The molar ratio of (0.11mmol), H2OBA and Sm (NO3) 3 are 1: 2.2, and solvent-thermal method obtains target compound, yield 79%.
Embodiment 4
It is similar to Example 1, unlike:The molar ratio of water and DMF are 1: 2, and solvent-thermal method obtains target compound, production Rate 71%.
Embodiment 5
It is similar to Example 1, unlike:The molar ratio of water and DMF are 1: 3.5, and solvent-thermal method obtains target compound, Yield 83%.
Embodiment 6
It is similar to Example 1, unlike:Stirring 10 minutes, solvent-thermal method obtains target compound, yield 80%.
Embodiment 7
It is similar to Example 1, unlike:Stirring 30 minutes, solvent-thermal method obtains target compound, yield 86%.

Claims (3)

1. the preparation method of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agent of one kind, which is characterized in that including with Lower step:
(1) by H2OBA is dissolved in the in the mixed solvent of DMF and water, and rare earth nitrades Re (NO are added3)3, wherein Re La, Ce, One kind in tetra- kinds of rare earth elements of Sm, Er, H2OBA and Re (NO3)3Molar ratio be 1: 1.8, the in the mixed solvent water and DMF Molar ratio be 1: 3;
(2) 15min is stirred at room temperature after it becomes colorless clarification by cotton-shaped suspension in the solution of step (1), be packed into poly- In the reaction kettle of tetrafluoroethene liner, in 120 ± 1 DEG C of 70~72h of constant temperature;
(3) 10~12h is kept the temperature when the reactant after constant temperature being down to 100 ± 2 DEG C, room temperature is then down to the rate of 6 DEG C/h, is obtained To target product [Re2(OBA)3(H2O)5]·H2O。
2. the preparation method of as described in claim 14,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents, special Sign is:Step (2) thermostat temperature is 120 DEG C.
3. the preparation method of as described in claim 14,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents, special Sign is:The solution being fitted into step (2) in reaction kettle is 15mL.
CN201610559928.2A 2016-07-08 2016-07-08 The preparation method of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents Active CN106316826B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610559928.2A CN106316826B (en) 2016-07-08 2016-07-08 The preparation method of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610559928.2A CN106316826B (en) 2016-07-08 2016-07-08 The preparation method of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents

Publications (2)

Publication Number Publication Date
CN106316826A CN106316826A (en) 2017-01-11
CN106316826B true CN106316826B (en) 2018-10-09

Family

ID=57740830

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610559928.2A Active CN106316826B (en) 2016-07-08 2016-07-08 The preparation method of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents

Country Status (1)

Country Link
CN (1) CN106316826B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102617620A (en) * 2012-03-07 2012-08-01 上海师范大学 Heterocyclic ligand-containing efficiently-antibacterial rare earth ternary complexes, and preparation method and application thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102617620A (en) * 2012-03-07 2012-08-01 上海师范大学 Heterocyclic ligand-containing efficiently-antibacterial rare earth ternary complexes, and preparation method and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Structural diversity of luminescent lanthanide metal–organic frameworks based on a V-shaped ligand;Yan-Fei He等;《CrystEngComm》;20151231;第17卷;第2471-2478页 *
Synthesis, crystal structure and luminescent properties of new lanthanide-containing coordination polymers involving 4,49-oxy-bis-benzoate as ligand;Yun Luo等;《CrystEngComm》;20131231;第706-720页 *
Urothermal synthesis of photoluminescent lanthanide–organic frameworks with unusual topologies;Zhi-Qiang Jiang等;《CrystEngComm》;20131231;第15卷;第315-323页 *

Also Published As

Publication number Publication date
CN106316826A (en) 2017-01-11

Similar Documents

Publication Publication Date Title
CN103910679A (en) Method for preparing enzalutamide
CN102311355A (en) Preparation method of rofecoxib
CN102766050A (en) Method for synthesizing dimethyl fumarate
CN106565616A (en) Preparation method of antibacterial veterinary drug sulfamonomethoxine sodium
CN106316826B (en) The preparation method of 4,4 '-dicarboxydiphenyl ether rare earth complex compoud bacteriostatic agents
CN105541801B (en) The synthetic method of EZH2 methyltransferase inhibitors GSK126
CN101362684A (en) Solution containing vanadium oxalate and preparation method thereof
CN104844640B (en) Method for regulating morphology of amino acid/rare earth coordination polymer by using surfactant
CN103772400A (en) Preparation method of trans-5-chloro-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole
CN109134331B (en) Synthesis method of azithromycin genotoxic impurity
CN107587195B (en) Tantalum-based rare earth polyacid and preparation method of nanocrystalline thereof
CN106957270B (en) A kind of nitrouracil drug supermolecule eutectic and preparation method thereof
CN104788483A (en) A method of preparing phenylboronic acid ortho- meta- and para-substituted with hydroxy and mercapto
CN103588685B (en) Three ketones ammonium salt compound and preparation method thereof and application
CN104829447B (en) Continuous synthetic method of phenoxy acetic acid
CN104529726B (en) A kind of preparation method of o-hydroxyacetophenone
CN106905177A (en) A kind of preparation method of the biphenyl propionic acid ethyl ester derivative hydrochloride of 2 amino 3
CN102816201A (en) Purification method of abiraterone
CN102491992A (en) Method for preparing carbapenem type antibiotic key intermediate 4-BMA
CN1133613C (en) Process for synthesizing deoxypolyhydroxyl storax and its derivatives
CN101723864A (en) Method for preparing p-tert-butyl o-nitrothiophenol
CN102675259A (en) Method for preparing 16,17-dihydro-gibberellin 5 and preparing acetic ester thereof
CN103435503B (en) Preparation process of phenylephrine key intermediate 3-hydroxyl-alpha-(methylamine ethyl)-phenylcarbinol (dextro-laevo isomer)
CN113666812B (en) Synthesis method of 5-halogenated veratraldehyde
RU2504582C1 (en) Method of stabilising nanoparticles of biogenic elements with enzymes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant